Leader's Advantage Acquisition is a special purpose acquisition company formed to complete a merger, share acquisition, or similar business combination to take a private operating business public. The company has no commercial operations or standalone revenue, and it holds its initial capital in a trust account pending a transaction. Leader's Advantage focuses on acquisition targets in healthcare, specialty chemicals, pharmaceuticals, and defense, seeking to leverage the operational backgrounds and industry relationships of its leadership team from PMC Group. Under its business model, the company searches for an acquisition target within a defined 18-month window. Public investors receive shares paired with fractional warrants, which provide potential upside if the combined business performs well, while retaining redemption rights to recover their capital from the trust. If Leader's Advantage fails to complete a business combination within the required timeframe, the trust liquidates and returns funds to public shareholders, while the sponsor's founder shares and private placement warrants expire worthless.